SHIVOM MAIN/PUBLIC SALE STARTS TOMORROW: JOIN NOW

With the main purpose of integrating Genomics with blockchain, SHIVOM has done marvelously well with it project. This project has been one of the most successful projects I have ever witnessed in my cryptocurrency journey. Although the main sale starts tomorrow, SHIVOM was able to hit its soft cap even before it pre-sale. Is that not amazing of the project SHIVOM?

With this great and enthusiast team, SHIVOM wants to take genomics to a different level where only people who have access to their own data will benefit from it. In this situation, your genomic data is kept on the blockchain which promises to be very secured, you are the only one who can access it. In times where it is needed by an organization and you give it out to them, this is where SHIVOM will come in and pay you with some tokens.

Shivom wants to thank the everyone who participated in the private and presale of their token.
If you could not join the pre-sale this is your chance to make it. Never let this oppotunity escape you because this is the the time to invest in a great project. Once again let me tell you the success story of this project. Soft-Cap has been reached and the presale was also successful. Never be left out. Just click on this https://tokensale.shivom.io/users/sign_up to register for the main or public sale.

Make the right choice now and you will never regret. Be an OMIX token holder!!!!!!!!!!!!!

SHIVOM taken us to the moon!!!!!!!!!!!!

You can buy your tokens here- https://tokensale.shivom.io/users/sign_up

For more details on our ongoing project,

You can Visit our Website- https://shivom.io/

Also Read more on our Whitepaper- https://shivom.io/files/Shivom-Executive-Summary.pdf

Follow our twitter page (46k+ as at now) — https://twitter.com/projectshivom

Join our Telegram group (70k+ as at now)- https://t.me/projshivom

Like our facebook page- https://www.facebook.com/ProjectShivom

ANN Thread- https://bitcointalk.org/index.php?topic=3204563.0

Bounty Thread- https://bitcointalk.org/index.php?topic=3183600.0

Authorship